Soleus Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Buy |
76,493
+4,193
| +6% | +$55K | 0.07% | 82 |
|
|
2025
Q1 | $1.59M | Sell |
72,300
-111,000
| -61% | -$2.44M | 0.11% | 64 |
|
|
2024
Q4 | $4.89M | Buy |
+183,300
| New | +$4.89M | 0.31% | 53 |
|
|
2021
Q4 | – | Sell |
-31,300
| Closed | -$520K | – | 77 |
|
|
2021
Q3 | $520K | Hold |
31,300
| – | – | 0.08% | 72 |
|
|
2021
Q2 | $668K | Sell |
31,300
-68,700
| -69% | -$1.47M | 0.1% | 62 |
|
|
2021
Q1 | $3.25M | Buy |
+100,000
| New | +$3.25M | 0.59% | 37 |
|